The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Abstract
Glioblastoma ranks among the most lethal of all human cancers. Glioblastomas display striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex. Although the original identification of GSCs dates back more than a decade, the purification and characterization of GSCs remains challenging. Despite these challenges, the evidence that GSCs play important roles in tumor growth and response to therapy has grown. Like normal stem cells, GSCs are functionally defined and distinguished from their differentiated tumor progeny at core transcriptional, epigenetic, and metabolic regulatory levels, suggesting that no single therapeutic modality will be universally effective against a heterogenous GSC population. Glioblastomas induce a systemic immunosuppression with mixed responses to oncoimmunologic modalities, suggesting the potential for augmentation of response with a deeper consideration of GSCs. Unfortunately, the GSC literature has been complicated by frequent use of inferior cell lines and a lack of proper functional analyses. Collectively, glioblastoma offers a reliable cancer to study cancer stem cells to better model the human disease and inform improved biologic understanding and design of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are considered tumor-initiating cells that render cancer resistant to conventional anti-glioblastoma therapies,90,91,92,93 leading to inevitable recurrence and fatal outcomes.94,95”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“…& DEVELOPMENT 597 GSC metabolism: fueling tumor growth The metabolic dysregulation of cancer cells has been well documented for centuries and has served as an integral component of our understanding of cancer initiation, growth, and adaptation (Hanahan and Weinberg 2011; Pavlova and Thompson 2016).”
BackgroundSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Flagged first, then by citations
Research works printed but not linked: 166
- 10.1016/j.ccr.2008.12.006 · DOI · Paper page
- 10.1016/j.ccell.2015.09.007 · DOI
- 10.1073/pnas.0530291100 · DOI
- 10.1016/j.stem.2016.12.001 · DOI
- 10.1101/gad.294991.116 · DOI
- 10.1016/j.trecan.2017.12.008 · DOI
- 10.1016/S1535-6108(02)00046-6 · DOI
- 10.1126/scitranslmed.aah6510 · DOI
- 10.1038/nature05236 · DOI
- 10.1158/0008-5472.CAN-06-1010 · DOI
- 10.1016/j.ccell.2016.08.017 · DOI
- 10.1038/s41556-018-0183-3 · DOI
- 10.1158/0008-5472.CAN-06-4180 · DOI
- 10.1016/j.ccell.2017.10.006 · DOI
- 10.1038/ng.3967 · DOI · Paper page
- 10.1038/ncomms15223 · DOI
- 10.1038/s41592-018-0070-7 · DOI
- 10.1007/s00109-008-0357-8 · DOI
- 10.1038/nm0797-730 · DOI
- 10.1016/j.ccell.2017.08.018 · DOI
- 10.1155/2012/376894 · DOI
- 10.1056/NEJMoa1610497 · DOI
- 10.1101/gad.293027.116 · DOI
- 10.1016/j.cell.2015.12.028 · DOI
- 10.1158/1078-0432.CCR-17-0605 · DOI
- 10.1016/j.cell.2013.02.021 · DOI · Paper page
- 10.1016/j.ccell.2015.09.021 · DOI
- 10.1038/s41556-018-0126-z · DOI
- 10.1038/s41591-018-0135-2 · DOI
- 10.1038/nn.4620 · DOI
- 10.1158/0008-5472.CAN-05-2018 · DOI
- 10.1186/s13059-016-0990-4 · DOI
- 10.1016/j.ccell.2017.10.016 · DOI
- 10.1016/j.celrep.2017.02.059 · DOI
- 10.1371/journal.pone.0052113 · DOI
- 10.1056/NEJMoa1716435 · DOI
- 10.1016/j.ccell.2016.05.002 · DOI
- 10.1371/journal.pone.0169932 · DOI
- 10.1038/nature11112 · DOI · Paper page
- 10.1038/ncomms10068 · DOI
- 10.1158/0008-5472.CAN-16-2524 · DOI
- 10.1126/science.aao4750 · DOI
- 10.1038/nn.3510 · DOI
- 10.1038/nature25171 · DOI
- 10.1158/ajc.1937.276 · DOI
- 10.1158/0008-5472.CAN-04-1364 · DOI
- 10.1016/j.ccell.2015.10.005 · DOI
- 10.1038/ncomms11960 · DOI
- 10.1002/jcb.22350 · DOI
- 10.1016/j.ccell.2018.03.020 · DOI
- 10.1126/scisignal.2000446 · DOI · Paper page
- 10.1016/j.stem.2017.04.009 · DOI
- 10.1007/s11060-015-1947-2 · DOI
- 10.1593/tlo.09100 · DOI
- 10.1038/srep11483 · DOI
- 10.1093/neuonc/nov107 · DOI
- 10.1073/pnas.2036535100 · DOI
- 10.1038/nrm.2017.130 · DOI · Paper page
- 10.1158/2159-8290.CD-14-0001 · DOI
- 10.1038/s41586-018-0810-y · DOI · Paper page
- 10.1016/j.celrep.2015.04.021 · DOI
- 10.15252/embj.201798772 · DOI
- 10.1126/science.284.5422.1994 · DOI
- 10.1038/75596 · DOI
- 10.1002/stem.2053 · DOI
- 10.1016/j.cell.2016.10.039 · DOI
- 10.1016/j.cell.2018.09.038 · DOI
- 10.1016/j.ccell.2017.11.005 · DOI
- 10.1101/gad.212548.112 · DOI
- 10.1158/0008-5472.CAN-15-2402 · DOI
- 10.4161/cc.8.22.9893 · DOI
- 10.1101/gad.188292.112 · DOI
- 10.1158/0008-5472.CAN-17-0468 · DOI
- 10.1038/nm.4415 · DOI
- 10.1172/jci.insight.90019 · DOI
- 10.4143/crt.2017.307 · DOI
- 10.1038/s41586-018-0792-9 · DOI · Paper page
- 10.1073/pnas.1303607110 · DOI · Paper page
- 10.1016/j.ccell.2015.07.013 · DOI
- 10.1038/s41591-018-0156-x · DOI
- 10.1101/gad.257394.114 · DOI
- 10.7554/eLife.14845 · DOI
- 10.1038/nature23666 · DOI
- 10.1016/j.celrep.2018.12.090 · DOI · Paper page
- 10.1016/j.ccr.2006.03.030 · DOI
- 10.1038/nature16475 · DOI
- 10.1038/s41586-018-0389-3 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-2030 · DOI
- 10.1016/j.molcel.2017.04.026 · DOI
- 10.1016/j.ccell.2016.11.017 · DOI
- 10.1016/j.stem.2016.11.003 · DOI · Paper page
- 10.1186/1476-4598-5-67 · DOI
- 10.1016/j.molcel.2015.09.002 · DOI
- 10.1016/j.ccr.2012.05.037 · DOI
- 10.1038/nature25169 · DOI
- 10.1016/j.stem.2017.10.005 · DOI
- 10.1016/j.ccell.2018.08.003 · DOI
- 10.1038/nature23000 · DOI · Paper page
- 10.1038/ncb3429 · DOI
- 10.1038/nature14320 · DOI
- 10.1007/s11060-017-2626-2 · DOI
- 10.1016/j.ccell.2017.03.011 · DOI
- 10.1038/nature05372 · DOI
- 10.1038/s41467-018-03731-w · DOI
- 10.1126/scitranslmed.aaa0984 · DOI
- 10.1038/nature16071 · DOI
- 10.1093/neuonc/nov189 · DOI
- 10.1002/stem.2393 · DOI
- 10.1158/1078-0432.CCR-16-1323 · DOI
- 10.1016/j.stem.2017.06.004 · DOI
- 10.1016/j.stem.2011.04.007 · DOI
- 10.1016/j.ccell.2018.05.012 · DOI
- 10.1016/j.stem.2014.01.005 · DOI
- 10.1016/j.molonc.2015.03.007 · DOI · Paper page
- 10.1016/j.stem.2009.03.014 · DOI · Paper page
- 10.1016/j.cell.2015.09.004 · DOI · Paper page
- 10.1158/1078-0432.CCR-16-1518 · DOI
- 10.1158/1078-0432.CCR-10-2563 · DOI
- 10.1158/1078-0432.CCR-12-1940 · DOI
- 10.1126/science.aaf2666 · DOI
- 10.1016/j.cell.2017.07.016 · DOI
- 10.1126/science.aad3018 · DOI
- 10.1038/nature05384 · DOI
- 10.1016/j.ccell.2017.07.006 · DOI
- 10.1038/s41598-018-20929-6 · DOI
- 10.1158/0008-5472.CAN-16-2171 · DOI
- 10.1016/j.ccell.2015.09.002 · DOI
- 10.1038/ncomms15080 · DOI
- 10.1126/scitranslmed.aah6816 · DOI
- 10.1038/ng.3711 · DOI
- 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821
- 10.1038/nature03128 · DOI
- 10.1016/j.celrep.2016.12.064 · DOI
- 10.1016/j.stem.2009.03.003 · DOI
- 10.1002/1878-0261.12174 · DOI
- 10.1016/S1470-2045(09)70025-7 · DOI
- 10.1001/jama.2017.18718 · DOI · Paper page
- 10.1038/nature25170 · DOI
- 10.1016/j.brainres.2011.03.013 · DOI
- 10.15252/emmm.201505495 · DOI
- 10.1038/nature20123 · DOI
- 10.1038/s41588-017-0001-z · DOI
- 10.1038/nchembio.1204 · DOI
- 10.1093/neuonc/noy082 · DOI
- 10.1016/j.cell.2015.04.012 · DOI
- 10.1038/nature24014 · DOI
- 10.1126/science.aai8478 · DOI
- 10.1016/j.ccell.2016.09.008 · DOI
- 10.1038/onc.2017.351 · DOI
- 10.1158/0008-5472.CAN-08-3886 · DOI
- 10.1111/j.1750-3639.2010.00379.x · DOI
- 10.1016/j.ccell.2017.06.003 · DOI
- 10.1158/0008-5472.CAN-17-0114 · DOI
- 10.1038/nn.4537 · DOI
- 10.1038/s41593-018-0285-z · DOI
- 10.1172/JCI86114 · DOI
- 10.1016/j.cell.2018.10.006 · DOI
- 10.1111/jcmm.13667 · DOI
- 10.1371/journal.pone.0147717 · DOI
- 10.1016/j.ccell.2017.02.013 · DOI
- 10.1016/j.molcel.2018.06.023 · DOI
- 10.1186/s12943-017-0628-5 · DOI
- 10.1016/j.stem.2017.10.002 · DOI
- 10.1186/s13059-018-1420-6 · DOI
- 10.1016/j.ccr.2005.07.004 · DOI
- 10.1084/jem.20171093 · DOI
Cited by
Sorted by citations
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Metadata
- Authors
- Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2019-06-01
- Volume
- 33
- Issue
- 11-12
- Pages
- 591-609
- ISSN
- 0890-9369
- 1549-5477
- PMC
- PMC6546059
- Cited by
- 514
- References
- 21
- Language
- en
- Funders
- National Institutes of Health (CA217065, CA197718, CA154130, CA169117, CA171652, NS087913, NS089272, NS103434)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
